References 1.Ballatori, N., Krance, S
These pharmacokinetic data allow a once-weekly subcutaneous injection regimen
Keep records of storage conditions, take photos of packaging damage if present, and document the date and circumstances of exposure to support your replacement request
In comparison to treatment with 3.0 mg of liraglutide, the treatment group administered a 4.5 mg dose of cagrilintide experienced a greater reduction in weight loss by 1.8%
Ajabnoor GMA, Hashim KT, Alzahrani MM, Alsuheili AZ, Alharbi AF, Alhozali AM, Enani S, Eldakhakhny B, Elsamanoudy A (2023) The possible effect of the long-term use of glucagon-like peptide-1 receptor agonists (GLP-1RA) on Hba1c and lipid profile in type 2 diabetes mellitus: a retrospective study in KAUH, Jeddah, Saudi Arabia